Skip to main content
    I

    Intelligent Bio Solutions Inc. (INBS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.52
    -0.24 (-13.64%)

    Market Cap: $5.84M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    39%(7/18)
    Avg Surprise
    -80.15%
    Streak
    1 Q

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$1.36
    Range-$1.36 - -$1.36
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago-$1.360.0%
    30d ago-$1.360.0%
    7d ago-$1.360.0%
    Current-$1.36
    Revenue Consensus
    $1.40M
    Range$1.40M - $1.40M
    1 analysts
    Report date not yet scheduledPeriod ending Mar 31, 2027
    EPS Consensus-$1.33
    Range-$1.33 - -$1.33
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago-$1.330.0%
    30d ago-$1.330.0%
    7d ago-$1.330.0%
    Current-$1.33
    Revenue Consensus
    $1.50M
    Range$1.50M - $1.50M
    1 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.39xFCF Yield-253.24%
    Profitability
    Profit Margin-269.30%Operating Margin-272.60%
    ROE-225.30%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest Coverage-1482.43x
    Current Ratio1.98xQuick Ratio1.87x
    Trading Statistics
    Beta4.49Avg Volume39.68K
    52-Week High$24.9052-Week Low$1.35

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 14.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 40.1, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$1.91
    SMA 20$1.80
    SMA 50$1.77
    SMA 200$2.69
    EMA 10$1.85
    EMA 20$1.82
    EMA 50$1.85
    EMA 200$3.50

    MACD

    Line: 0.04Signal: 0.05Hist: -0.01

    ADX

    ADX: 21.7+DI: 24.2-DI: 31.7

    Aroon & PSAR

    Aroon Up80.0
    Aroon Down8.0
    PSAR$2.34

    Bollinger Bands

    Upper Band$2.22
    Lower Band$1.39
    %B Position4591%(Upper)
    Band Width0.16

    RSI (14-Day)

    Neutral
    40.1

    Momentum Oscillators

    Stoch %K22.3
    Stoch %D44.4
    Williams %R-97.6
    ROC (10d)-8.4%
    Momentum-0.14
    CCI (20d)-92.4
    MFI (14d)51.9

    Volatility Measures

    ATR (14d)$0.18(12.0%)
    StdDev (20d)0.21
    Hist Vol123.1%(High)

    Volume Flow

    VWAP$1.60
    OBV120.4M
    AD Line7.4B
    CMF (20d)0.022

    Volume Metrics

    Avg Vol (20d)41.0K
    Vol Ratio1.5x
    VWMA (20d)$1.91

    Pivot Points

    R3$2.19
    R2$2.08
    R1$1.92
    Pivot Point$1.81
    S1$1.65
    S2$1.54
    S3$1.38

    Advanced Oscillators

    TSI6.20
    Ultimate Osc46.7
    KST154.77

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about INBS

    News

    INBS Valuation

    GNG's valuation label for INBS is Undervalued.

    P/FCF
    -0.4x
    P/B
    0.6x
    INBS valuation multiples

    INBS Profitability: Margins, ROIC and FCF

    Intelligent Bio Solutions (INBS) has a gross margin of 50.9%, an operating margin of -272.6% and a net margin of -269.3%. It posts a -265.0% FCF margin.

    Gross margin
    50.9%
    Operating margin
    -272.6%
    Net margin
    -269.3%
    ROE
    -225.3%
    FCF margin
    -265.0%
    FCF yield
    -253.2%
    INBS financial statements

    Intelligent Bio Solutions Competitors

    The companies most similar to Intelligent Bio Solutions (INBS) include Trinity Biotech, Volitionrx and Neuroone Medical Technologies.

    Sector: Healthcare

    Companies most similar to Intelligent Bio Solutions

    INBS Bull Case vs Bear Case

    Bull case

    • INBS grew quarterly revenue 25.2% year over year.

    Bear case

    • INBS has a -269.3% net profit margin.
    • INBS beat EPS estimates in 12.5% of its last 8 reported quarters.

    INBS Earnings: Beat Rate and Next Report

    Intelligent Bio Solutions (INBS) beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate (12.5%).

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -185.6%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$1.36
    Estimate revisions (30 days, fiscal period ending Dec 31, 2026)
    0 up, 0 down
    INBS earnings history

    INBS ETF Holders

    Updated Nov 10, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About INBS

    Does INBS pay dividends?

    Intelligent Bio Solutions Inc. (INBS) does not currently pay a regular dividend.

    What is INBS's market cap?

    Intelligent Bio Solutions Inc. (INBS) has a market capitalization of $5.84M with a current stock price of $1.52.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.